a2z Radiology AI vs Claude
Side-by-side comparison of AI visibility scores, market position, and capabilities
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
About
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Claude 3.5 Sonnet topped coding and reasoning benchmarks in 2024; Claude 3.7 Sonnet with extended thinking launched in February 2025 as the leading model for complex professional tasks.
About
Claude is Anthropic's AI assistant, first released publicly in March 2023 and now one of the top three most-used AI assistants globally. Claude 3.5 Sonnet (June 2024) set benchmarks for coding, analysis, and instruction-following that led many developers and enterprises to migrate from GPT-4. Claude is available via claude.ai (free and Pro tiers at $20/month) and through the Anthropic API powering thousands of enterprise applications.
AI Visibility Head-to-Head
Key Details
Capabilities & Ecosystem
Capabilities
Also Compare
Track AI Visibility in Real Time
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.